Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia.

STAT3 STAT5b T-LGL leukemia (T-LGLL) chronic lymphoproliferative disease of NK cells (CLPD-NK) large granular lymphocyte (LGL) mutation

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 21 11 2019
accepted: 28 01 2020
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 7 3 2020
Statut: epublish

Résumé

Large granular lymphocyte leukemia (LGLL) is a chronic proliferation of clonal cytotoxic lymphocytes, usually presenting with cytopenias and yet lacking a specific therapy. The disease is heterogeneous, including different subsets of patients distinguished by LGL immunophenotype (CD8+ Tαβ, CD4+ Tαβ, Tγδ, NK) and the clinical course of the disease (indolent/symptomatic/aggressive). Even if the etiology of LGLL remains elusive, evidence is accumulating on the genetic landscape driving and/or sustaining chronic LGL proliferations. The most common gain-of-function mutations identified in LGLL patients are on

Identifiants

pubmed: 32133291
doi: 10.3389/fonc.2020.00152
pmc: PMC7040228
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

152

Informations de copyright

Copyright © 2020 Teramo, Barilà, Calabretto, Vicenzetto, Gasparini, Semenzato and Zambello.

Références

Leukemia. 2015 Apr;29(4):886-94
pubmed: 25306898
Cancer Sci. 2014 Mar;105(3):342-6
pubmed: 24350896
Blood Cancer J. 2018 Jun 5;8(6):51
pubmed: 29891951
Leuk Lymphoma. 2018 Feb;59(2):416-422
pubmed: 28633612
J Clin Invest. 2001 Feb;107(3):351-62
pubmed: 11160159
Leukemia. 2016 May;30(5):1204-8
pubmed: 26419508
Int J Hematol. 2019 May;109(5):563-571
pubmed: 30859397
Haematologica. 2014 Dec;99(12):1826-33
pubmed: 25193965
Leukemia. 2019 Nov 18;:
pubmed: 31740810
Blood. 2012 Oct 11;120(15):3048-57
pubmed: 22859607
J Hematol Oncol. 2013 Oct 31;6:82
pubmed: 24283217
Blood Adv. 2017 Sep 13;1(21):1786-1789
pubmed: 29296824
Cancers (Basel). 2019 Dec 03;11(12):
pubmed: 31817042
J Clin Pharmacol. 2020 Feb;60(2):264-273
pubmed: 31465127
Am Soc Clin Oncol Educ Book. 2018 May 23;38:616-625
pubmed: 30231346
Oncotarget. 2017 Oct 9;8(55):93299-93300
pubmed: 29212142
Cancer. 1987 Dec 15;60(12):2971-8
pubmed: 3677021
Leukemia. 2015 Dec;29(12):2427-9
pubmed: 26449659
Nat Commun. 2018 Apr 19;9(1):1567
pubmed: 29674644
Int J Lab Hematol. 2018 May;40 Suppl 1:97-103
pubmed: 29741263
N Engl J Med. 2012 May 17;366(20):1905-13
pubmed: 22591296
Blood Adv. 2019 Mar 26;3(6):917-921
pubmed: 30898763
Hum Pathol. 2018 Mar;73:74-81
pubmed: 29288042
Am J Hematol. 2017 Jan;92(1):E6-E8
pubmed: 27761930
Br J Haematol. 2018 Mar;180(6):911-915
pubmed: 28025836
Blood. 2015 Jan 22;125(4):639-48
pubmed: 25349174
Leukemia. 2013 Jul;27(7):1598-600
pubmed: 23207521
Cancer Cell. 2012 Nov 13;22(5):645-55
pubmed: 23153537
Int J Cancer. 2016 Jan 1;138(1):121-4
pubmed: 26199174
Haematologica. 2015 Jan;100(1):91-9
pubmed: 25281507
Blood. 2017 Mar 2;129(9):1082-1094
pubmed: 28115367
J Mol Diagn. 2014 Jul;16(4):382-92
pubmed: 24797340
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16308-13
pubmed: 18852469
Oncotarget. 2017 Jun 27;8(37):61876-61889
pubmed: 28977911
Blood. 2013 May 9;121(19):3843-54, S1
pubmed: 23515927
Front Immunol. 2014 Feb 26;5:72
pubmed: 24616720
Leukemia. 2013 Nov;27(11):2244-7
pubmed: 23563237
Haematologica. 2019 Aug 29;:
pubmed: 31467122
Haematologica. 2013 Nov;98(11):1748-52
pubmed: 23872306
J Exp Med. 2001 Jan 15;193(2):219-31
pubmed: 11208862
Ann Oncol. 2014 Oct;25(10):2030-5
pubmed: 25096606
Best Pract Res Clin Haematol. 2019 Sep;32(3):207-216
pubmed: 31585621
J Clin Invest. 2018 Jan 2;128(1):387-401
pubmed: 29200404
Nat Rev Cancer. 2004 Feb;4(2):97-105
pubmed: 14964307
Transl Med UniSa. 2014 Feb 04;8:4-11
pubmed: 24778993
Cancers (Basel). 2019 Dec 19;12(1):
pubmed: 31861597
Leukemia. 2017 May;31(5):1243-1246
pubmed: 28167832
Nat Commun. 2017 Jun 21;8:15869
pubmed: 28635960
Haematologica. 2009 Oct;94(10):1341-5
pubmed: 19794080
Blood. 2016 Nov 17;128(20):2465-2468
pubmed: 27697773
Blood. 2013 May 30;121(22):4541-50
pubmed: 23596048
Blood. 2013 Dec 12;122(25):4077-85
pubmed: 24149287
Blood Cancer J. 2013 Dec 06;3:e168
pubmed: 24317090
Cytokine Growth Factor Rev. 2019 Oct;49:10-22
pubmed: 31677966
Leukemia. 2019 Sep;33(9):2336-2340
pubmed: 30967617

Auteurs

Antonella Teramo (A)

Hematology and Clinical Immunology Section, Department of Medicine (DIMED), Padova University School of Medicine, Padova, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Gregorio Barilà (G)

Hematology and Clinical Immunology Section, Department of Medicine (DIMED), Padova University School of Medicine, Padova, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Giulia Calabretto (G)

Hematology and Clinical Immunology Section, Department of Medicine (DIMED), Padova University School of Medicine, Padova, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Cristina Vicenzetto (C)

Hematology and Clinical Immunology Section, Department of Medicine (DIMED), Padova University School of Medicine, Padova, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Vanessa Rebecca Gasparini (VR)

Hematology and Clinical Immunology Section, Department of Medicine (DIMED), Padova University School of Medicine, Padova, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Gianpietro Semenzato (G)

Hematology and Clinical Immunology Section, Department of Medicine (DIMED), Padova University School of Medicine, Padova, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Renato Zambello (R)

Hematology and Clinical Immunology Section, Department of Medicine (DIMED), Padova University School of Medicine, Padova, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Classifications MeSH